{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:55:22Z","timestamp":1788479722935,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003062","name":"Erciyes University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We aimed to investigate the prevalence and the diagnostic criteria of hypoprolactinemia in patients with panhypopituitarism and the effects of hypoprolactinemia on depression and sexual functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Forty-eight patients with panhypopituitarism and 20 healthy volunteers were included. Basal hormone levels were measured and a TRH stimulation test was performed. For the evaluation of sexual functions, questionnaries of Female Sexual Functional Index (FSFI) for females and International Erectile Functional Index for males were performed to the subjects. Depressive symptoms were evaluated by Beck Depression Envontory score (BDI-II).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The peak PRL response to TRH stimulation test at 5th percentile in the control group was 18.6 ng\/ml in males and 41.6 ng\/ml in females and accepted as the cut-offs for sufficient response of PRL. Prolactin was insufficient in 42(87.5%) patients. A basal PRL level of \u2264\u20095.7 ng\/ml in males and 7.11 ng\/ml in females was 100% specific in predicting an inadequate response to TRH stimulation test with 80% and 70% sensitivity respectively. A basal PRL level of \u2265\u20098.5 ng\/dl in males was 100% specific and 76% sensitive, and in females a level of \u2265\u200915.2 ng\/dl was 96% specific and 66% sensitive in predicting an adequate response to TRH. PRL deficient patients with panhypopituitarism had higher depression scores compared to the controls, lower sexual function scores in males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PRL deficiency is prevalent among individuals with panhypopituitarism, with the potential to result in elevated depression scores in both sexes and impaired sexual functions in males. A basal PRL level seems to be sufficient for the diagnosis of hypoprolactinemia in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-024-01393-0","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T09:01:34Z","timestamp":1714726894000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4927-6847","authenticated-orcid":false,"given":"Ilknur","family":"Uzun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-2352","authenticated-orcid":false,"given":"Zuleyha","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6197-5659","authenticated-orcid":false,"given":"Aysa","family":"Hacio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-7433","authenticated-orcid":false,"given":"Kursad","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-4683","authenticated-orcid":false,"given":"Fahrettin","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631","journal-title":"Physiol Rev"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.7221563","volume":"212","author":"D Owerbach","year":"1981","unstructured":"Owerbach D, Rutter WJ, Cooke NE, Martial JA, Shows TB (1981) The prolactin gene is located on chromosome 6 in humans. Science 212:815\u2013816","journal-title":"Science"},{"key":"1393_CR3","doi-asserted-by":"crossref","unstructured":"Karaca Z, Unluhizarci K, Kelestimur F (2023) Hypoprolactinemia. Does it matter? Redefining the hypopituitarism and return from a mumpsimus: absence of proof is not the proof of absence. Rev Endocr Metab Disord","DOI":"10.1007\/s11154-023-09847-9"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"16092","DOI":"10.1038\/nrdp.2016.92","volume":"2","author":"Z Karaca","year":"2016","unstructured":"Karaca Z, Laway BA, Dokmetas HS, Atmaca H, Kelestimur F (2016) Sheehan syndrome. Nat Rev Dis Primers 2:16092","journal-title":"Nat Rev Dis Primers"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000527333","volume":"147","author":"R Krysiak","year":"2022","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Cabergoline-induced hypoprolactinemia may attenuate cardiometabolic effects of atorvastatin: a pilot study. Cardiology 147:497\u2013506","journal-title":"Cardiology"},{"key":"1393_CR6","doi-asserted-by":"crossref","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Cardiometabolic profile of young women with hypoprolactinemia. Endocrine, 78:135\u2013141","DOI":"10.1007\/s12020-022-03145-1"},{"key":"1393_CR7","first-page":"191","volume":"26","author":"R Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Rev Endocr Metab Disord 26:191\u2013208","journal-title":"Rev Endocr Metab Disord"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822\u2013830","journal-title":"Urology"},{"key":"1393_CR9","unstructured":"Beck ATSR, Brown GK (1996) Psychological Corporation. 2. ed"},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1743-6109.2008.01206.x","volume":"6","author":"G Corona","year":"2009","unstructured":"Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M et al (2009) Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med 6:1457\u20131466","journal-title":"J Sex Med"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-14-0244","volume":"171","author":"H Diri","year":"2014","unstructured":"Diri H, Tanriverdi F, Karaca Z, Senol S, Unluhizarci K, Durak AC et al (2014) Extensive investigation of 114 patients with Sheehan\u2019s syndrome: a continuing disorder. Eur J Endocrinol 171:311\u2013318","journal-title":"Eur J Endocrinol"},{"key":"1393_CR12","doi-asserted-by":"publisher","first-page":"1001703","DOI":"10.3389\/fendo.2022.1001703","volume":"13","author":"Y Macotela","year":"2022","unstructured":"Macotela Y, Ruiz-Herrera X, V\u00e1zquez-Carrillo DI, Ram\u00edrez-Hernandez G, de la Mart\u00ednez G, Clapp C (2022) The beneficial metabolic actions of prolactin. Front Endocrinol (Lausanne) 13:1001703","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1365-2265.2003.01916.x","volume":"59","author":"A Mukherjee","year":"2003","unstructured":"Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM (2003) Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clin Endocrinol 59:743\u2013748","journal-title":"Clin Endocrinol"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1210\/jc.2005-2491","volume":"91","author":"A Mukherjee","year":"2006","unstructured":"Mukherjee A, Ryder WD, J\u00f6stel A, Shalet SM (2006) Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults. J Clin Endocrinol Metab 91:2520\u20132525","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1445-5994.1976.tb03288.x","volume":"6","author":"SJ Judd","year":"1976","unstructured":"Judd SJ, Lazarus L (1976) A combined test of anterior pituitary reserve. Aust N Z J Med 6:30\u201336","journal-title":"Aust N Z J Med"},{"key":"1393_CR16","first-page":"826","volume":"30","author":"N Ozbey","year":"1994","unstructured":"Ozbey N, Inanc S, Aral F, Azezli A, Orhan Y, Sencer E et al (1994) Clinical and laboratory evaluation of 40 patients with Sheehan\u2019s syndrome. Isr J Med Sci 30:826\u2013829","journal-title":"Isr J Med Sci"},{"key":"1393_CR17","first-page":"3507","volume":"80","author":"BM Arafah","year":"1995","unstructured":"Arafah BM, Nekl KE, Gold RS, Selman WR (1995) Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. J Clin Endocrinol Metab 80:3507\u20133512","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/thy.2006.0311","volume":"17","author":"H Atmaca","year":"2007","unstructured":"Atmaca H, Tanriverdi F, Gokce C, Unluhizarci K, Kelestimur F (2007) Do we still need the TRH stimulation test? Thyroid 17:529\u2013533","journal-title":"Thyroid"},{"key":"1393_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0015-0282(16)48319-6","volume":"43","author":"RL Barbieri","year":"1985","unstructured":"Barbieri RL, Cooper DS, Daniels GH, Nathan D, Klibanski A, Ridgway EC (1985) Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease. Fertil Steril 43:66\u201373","journal-title":"Fertil Steril"},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jcem-44-5-809","volume":"44","author":"DL Healy","year":"1977","unstructured":"Healy DL, Pepperell RJ, Stockdale J, Bremner WJ, Burger HG (1977) Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing. J Clin Endocrinol Metab 44:809\u2013819","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR21","doi-asserted-by":"publisher","first-page":"832361","DOI":"10.3389\/fendo.2022.832361","volume":"13","author":"C Rodier","year":"2022","unstructured":"Rodier C, Courbi\u00e8re B, Fernandes S, Vermalle M, Florence B, Resseguier N et al (2022) Metoclopramide Test in Hyperprolactinemic Women with polycystic ovarian syndrome: old wine into new bottles? Front Endocrinol (Lausanne) 13:832361","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1393_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1210\/jcem-43-3-679","volume":"43","author":"JR Sowers","year":"1976","unstructured":"Sowers JR, McCallum RW, Hershman JM, Carlson HE, Sturdevant RA, Meyer N (1976) Comparison of metoclopramide with other dynamic tests of prolactin secretion. J Clin Endocrinol Metab 43:679\u2013681","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF03346292","volume":"30","author":"Y Toledano","year":"2007","unstructured":"Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268\u2013273","journal-title":"J Endocrinol Invest"},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/cen.12183","volume":"79","author":"V Chirico","year":"2013","unstructured":"Chirico V, Cannav\u00f2 S, Lacquaniti A, Salpietro V, Mandolfino M, Romeo PD et al (2013) Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction. Clin Endocrinol 79:537\u2013544","journal-title":"Clin Endocrinol"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6823-13-12","volume":"13","author":"L Balbach","year":"2013","unstructured":"Balbach L, Wallaschofski H, V\u00f6lzke H, Nauck M, D\u00f6rr M, Haring R (2013) Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? BMC Endocr Disord 13:12","journal-title":"BMC Endocr Disord"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2337\/dc12-1893","volume":"36","author":"T Wang","year":"2013","unstructured":"Wang T, Lu J, Xu Y, Li M, Sun J, Zhang J et al (2013) Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study. Diabetes Care 36:1974\u20131980","journal-title":"Diabetes Care"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1210\/en.2008-1003","volume":"150","author":"C Huang","year":"2009","unstructured":"Huang C, Snider F, Cross JC (2009) Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 150:1618\u20131626","journal-title":"Endocrinology"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1210\/clinem\/dgac346","volume":"107","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Piro AL, Allalou A, Alexeeff SE, Dai FF, Gunderson EP et al (2022) Prolactin and maternal metabolism in Women with a recent GDM pregnancy and links to future T2D: the SWIFT Study. J Clin Endocrinol Metab 107:2652\u20132665","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR29","doi-asserted-by":"crossref","unstructured":"Cincotta AH (2023) Brain dopamine-clock interactions regulate cardiometabolic physiology: mechanisms of the observed cardioprotective effects of circadian-timed Bromocriptine-QR therapy in type 2 diabetes subjects. Int J Mol Sci 24","DOI":"10.3390\/ijms241713255"},{"key":"1393_CR30","first-page":"2912","volume":"39","author":"KE Moore","year":"1980","unstructured":"Moore KE, Demarest KT, Johnston CA (1980) Influence of prolactin on dopaminergic neuronal systems in the hypothalamus. Fed Proc 39:2912\u20132916","journal-title":"Fed Proc"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cen.14283","volume":"93","author":"R Krysiak","year":"2020","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2020) Sexual function and depressive symptoms in young women with hypoprolactinaemia. Clin Endocrinol 93:482\u2013488","journal-title":"Clin Endocrinol"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.endinu.2021.03.001","volume":"69","author":"R Krysiak","year":"2022","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: a pilot study. Endocrinol Diabetes Nutr) 69:279\u2013288","journal-title":"Endocrinol Diabetes Nutr)"},{"key":"1393_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11154-015-9322-3","volume":"16","author":"G Rastrelli","year":"2015","unstructured":"Rastrelli G, Corona G, Maggi M (2015) The role of prolactin in andrology: what is new? Rev Endocr Metab Disord 16:233\u2013248","journal-title":"Rev Endocr Metab Disord"},{"key":"1393_CR34","doi-asserted-by":"publisher","first-page":"e3021","DOI":"10.1210\/clinem\/dgab201","volume":"106","author":"M Moriwaki","year":"2021","unstructured":"Moriwaki M, Welt CK (2021) PRL mutation causing alactogenesis: insights into Prolactin structure and function relationships. J Clin Endocrinol Metab 106:e3021\u2013e3026","journal-title":"J Clin Endocrinol Metab"},{"key":"1393_CR35","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1542\/peds.2010-1627","volume":"127","author":"CE Powe","year":"2011","unstructured":"Powe CE, Puopolo KM, Newburg DS, L\u00f6nnerdal B, Chen C, Allen M et al (2011) Effects of recombinant human prolactin on breast milk composition. Pediatrics 127:e359\u2013366","journal-title":"Pediatrics"},{"issue":"5","key":"1393_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/nu11050974","volume":"11","author":"LE Grzeskowiak","year":"2019","unstructured":"Grzeskowiak LE, Wlodek ME, Geddes DT (2019) What evidence do we have for Pharmaceutical Galactagogues in the treatment of Lactation Insufficiency?-A narrative review. Nutrients 11(5):974","journal-title":"Nutrients"},{"key":"1393_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2265.1983.tb00017.x","volume":"19","author":"G Delitala","year":"1983","unstructured":"Delitala G, Grossman A, Besser GM (1983) The participation of hypothalamic dopamine in morphine-induced prolactin release in man. Clin Endocrinol 19:437\u2013444","journal-title":"Clin Endocrinol"},{"key":"1393_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/er.2009-0009","volume":"31","author":"C Vuong","year":"2010","unstructured":"Vuong C, Van Uum SH, O\u2019Dell LE, Lutfy K, Friedman TC (2010) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31:98\u2013132","journal-title":"Endocr Rev"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01393-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01393-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T04:15:11Z","timestamp":1717474511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01393-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01393-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"8 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethics committee of Erciyes University Medical School (Date 17.02.2021 \/ No. 2021\/133).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}